Association of viral load with HPV16 positive cervical cancer pathogenesis: Causal relevance in isolates harboring intact viral E2 gene

Virology

Volumn 402, Issue 1, 2010, Pages 197-202

  Das, Damayanti ^a   Bhattacharjee, Bornali ^b   Sen, Shrinka ^a   Mukhopadhyay, Indranil ^a   Sengupta, Sharmila ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cervical cancer; E2 disruption; High viral load; HPV16 infection; Intact E2 gene

Indexed keywords

GENOMIC DNA; VIRUS PROTEIN; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; RANK SUM TEST; UTERINE CERVIX CANCER; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; YOUNG ADULT;

EID: 77952565850     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.03.030     Document Type: Article

References (49)

1. Abba M.C.S., Mouron A., Gomez M.A., Dulout F.N., Golijow C.D. Association of human papillomavirus viral load with HPV16 and high-grade intraepithelial lesion. Int. J. Gynecol. Cancer 2003, 13:154-158.
2. Anderssen S., Safari H., Mints M., Lewensohn-Fuchs L., Gyllensten U.B., Johansson B. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer 2005, 92:2195-2200.
3. Arias-Pulido H., Peyton C.L., Joste N.E., Vargas H., Wheeler C.M. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol. 2006, 44:1755-1756.
4. Berg M., Stenlund A. Functional interactions between papillomavirus E1 and E2 proteins. J. Virol. 1997, 71:3853-3863.
5. Bhattacharjee B., Sengupta S. HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women. Gynecol. Oncol. 2006, 100:372-378.
6. Bhattacharjee B., Sengupta S. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 2006, 354:280-285.
7. Bhattacharjee B., Mandal N.R., Roy S., Sengupta S. Characterisation of sequence variations within HPV16 isolates among Indian women: prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis. Virology 2008, 377:143-150.
8. Bhattacharya P., Sengupta S. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 2007, 70:283-293.
9. Cheung J.L., Lo K.W., Cheung T.H., Tang J.W., Chan P.K. Viral load, E2 gene disruption status and lineage of human papillomavirus type 16 infections in cervical neoplasia. J. Infect. Dis. 2006, 194:1706-1712.
10. Cheung J.L.K., Cheung T.H., Tang J.W.T., Chan P.K.S. Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low grade cervical lesion to invasive cancer. J. Clin. Microbiol. 2008, 46:1356-1362.
11. Choo K.B., Cheung W.F., Liew L.N., Lee H.H., Han S.H. Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J. Virol. 1989, 63:782-789.
12. Cooper K., Herrington C.S., Stickland J.E., Evans M.F., McGee J.O. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J. Clin. Pathol. 1991, 44:990-996.
13. Cricca M., Morselli-Labate A.M., Venturoli S., Ambretti S., Gentilomi G.A., Gallinella G., Costa S., Musiani M., Zerbini M. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol. Oncol. 2007, 106:549-557.
14. Cullen A.P., Reid R., Lorincz A.T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive neoplasm. J. Virol. 1991, 65:606-612.
15. De Andrea M., Mondini M., Azzimonti B., Dell'Oste V., Germano S., Gaudino G., Musso T., Landolfo S., Gariglio M. Alpha- and beta-papillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res. 2007, 124:220-225.
16. de Boer M.A., Jordanova E.S., Kenter G.G., Peters A.A., Corver W.E., Trimbos J.B., Fleuren G.J. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin. Cancer Res. 2007, 13:132-138.
17. Duensing S., Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 2002, 62:7075-7082.
18. Franceschi S., Rajkumar R., Snijders P.J., Arslan A., Mahé C., Plummer M., Sankaranarayanan R., Cherian J., Meijer C.J., Weiderpass E. Papillomavirus infection in rural women in southern India. Br. J. Cancer 2005, 92:601-606.
19. Franco E.L., Coutlée F. Prognostic value of measuring load of human papillomavirus DNA in cervical samples: an elusive target. J. Natl. Cancer Inst. 2009, 101:153-161.
20. Gallo G., Bibbo M., Bagella L., Zamparelli A., Sanseverino F., Giovagnoli M.R., Vecchione A., Giordano A. Study of viral integration of HPV-16 in young patients with LSIL. J. Clin. Pathol. 2003, 56:532-536.
21. Gillitzer E., Chen G., Stenlund A. Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding. EMBO J. 2000, 19:3069-3079.
22. Häfner N., Driesch C., Gajda M., Jansen L., Kirchmayr R., Runnebaum I.B., Dürst M. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 2008, 27:1610-1617.
23. Hernandez-Hernandez D.M., Ornelas-Bernal L., Guido-Jiménez M., Apresa-Garcia T., Alvarado-Cabrero I., Salcedo-Vargas M., Mohar-Betancourt A., Garcia-Carranca A. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol. Oncol. 2003, 90:310-317.
24. Jaquelline G., Oliveira, Colf Leremy A., McBride Alison A. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1047-1052.
25. Jeon S., Lambert P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1654-1658.
26. Josefsson A.M., Magnusson P.K., Ylitalo N., Sørensen P., Qwarforth-Tubbin P., Andersen P.K., Melbye M., Adami H.O., Gyllensten U.B. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000, 355:2189-2193.
27. Kalantari M., Blennow E., Hagmar B., Johansson B. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn. Mol. Pathol. 2001, 10:46-54.
28. Kozuka T., Aoki Y., Nakagawa K., Ohtomo K., Yoshikawa H., Matsumoto K., Yoshiike K., Kanda T. Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies. Jpn. J. Cancer Res. 2000, 91:271-279.
29. Kristiansen E., Jenkins A., Holm R. Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J. Clin. Pathol. 1994, 47:253-256.
30. Kulmala S.M., Syrjänen S.M., Gyllensten U.B., Shabalova I.P., Petrovichev N., Tosi P., Syrjänen K.J., Johansson B.C. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J. Clin. Pathol. 2006, 59:513-517.
31. Laikangbam P., Sengupta S., Bhattacharya P., Duttagupta C., Singh T.D., Verma Y., Roy S., Das R., Mukhopadhyay S. A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India. Int. J. Gynecol. Cancer 2007, 17:107-117.
32. Matsukura T., Kanda T., Furuno A., Yoshikawa H., Kawana T., Howley P.M. Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from cervical carcinoma. J. Virol. 1986, 58:979-982.
33. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
34. Narayanan S., Abraham P., Peedicayil A., Sridharan G., Shaji R.V., Chandy G. E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent. Gynecol. Oncol. 2004, 95:363-369.
35. Peitsaro P., Johansson B., Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 2002, 40:886-891.
36. Roberts I., Ng G., Foster N., Stanley M., Herdman M.T., Pett M.R., Teschendorff A., Coleman N. Critical evaluation of HPV16 gene copy number quantification by SYBR green PCR. BMC Biotechnol. 2008, 8:57.
37. Saunier M., Monnier-Benoit S., Mauny F., Dalstein V., Briolat J., Riethmuller D., Kantelip B., Schwarz E., Mougin C., Prétet J.L. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16 infected women with high grade lesions or cervical carcinoma. J. Clin. Microbiol. 2008, 46:3678-3685.
38. Scheurer M.E., Dillon L.M., Chen Z., Follen M., Adler-Storthz K. Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens. Infect. Agent Cancer 2007, 2:8.
39. Schlecht N.F., Kulaga S., Robitaille J., Schlecht N.F., Kulaga S., Robitaille J., Ferreira S., Santos M., Miyamura R.A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., Franco E.L. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. J. Am. Med. Assoc. 2001, 286:3106-3114.
40. Sowjanya A.P., Jain M., Poli U.R., Padma S., Das M., Shah K.V., Rao B.N., Devi R.R., Gravitt P.E., Ramakrishna G. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh. India. BMC Infect. Dis. 2005, 5:116.
41. Swan D.C., Tucker R.A., Tortolero-Luna G., Mitchell M.F., Wideroff L., Unger E.R., Nisenbaum R.A., Reeves W.C., Icenogle J.P. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 1999, 37:1030-1034.
42. Tachezy R., Van Ranst M.A., Cruz Y., Burk R.D. Analysis of short novel human papillomavirus sequences. Biochem. Biophys. Res. Commun. 1994, 204:820-827.
43. Tan S.H., Leong L.E.C., Walker P.A., Bernard H.U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 1994, 68:6411-6420.
44. van Duin M., Snijders P.J., Schrijnemakers H.F., Voorhorst F.J., Rozendaal L., Nobbenhuis M.A., van den Brule A.J., Verheijen R.H., Helmhorst T.J., Meijer C.J. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int. J. Cancer 2002, 98:590-595.
45. Wang S.S., Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. J. Natl. Cancer Inst. Monogr. 2003, 31:35-40.
46. Wentzensen N., Vinokurova S., von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004, 64:3878-3884.
47. Woodman B.J.C., Collins S.I., Young L.S. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 2007, 7:11-22.
48. Yasugi T., Benson J.D., Sakai H., Vidal M., Howley P.M. Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J. Virol. 1997, 71:891-899.
49. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature 2002, 2:342-350.